老年跨性别与性别多元成人的激素管理:病例导向路径
本文以病例为基础,讨论老年跨性别与性别多元(TGD)成人在神经认知障碍、心血管疾病风险升高、前列腺癌、骨骼健康和绝经背景下启动或继续性别肯定激素治疗的考量。目前尚无针对TGD老年人的循证指南,文章结合TGD与顺性别成人的临床实践和研究数据提出管理思路,并指出未来研究可完善相关指南。
要点
- 老年TGD成人激素管理需兼顾性别肯定治疗与年龄相关疾病。
- 神经认知障碍、心血管风险、前列腺癌、骨骼健康和绝经是重点考量场景。
- 目前无针对TGD老年人的循证指南,决策参考TGD与顺性别成人数据。
核心结论
- 老年TGD成人的性别肯定激素治疗需结合年龄相关疾病个体化决策,现有证据不足以形成专门指南。
研究设计与样本
- 本文为病例导向的临床实践文章,讨论老年TGD成人在神经认知障碍、心血管疾病风险升高、前列腺癌、骨骼健康和绝经场景下的激素管理考量。
临床怎么用
- 在内分泌科实践中,对老年TGD成人启动或继续性别肯定激素治疗时,应评估神经认知障碍、心血管疾病风险、前列腺癌、骨骼健康和绝经等年龄相关情况。
局限性
- 目前缺乏针对老年TGD成人这些年龄相关疾病的循证指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As the general population continues to shift to an older demographic, more transgender and gender diverse (TGD) adults will seek out endocrinologists and other healthcare providers to help them navigate both initiation and continuation of gender-affirming hormone therapy concurrent with the potential development of age-associated diseases. The purpose of this Approach to the Patient article is a case-based approach to management considerations in older TGD adults in the settings of neurocognitive disorder, increased cardiovascular disease risk, prostate cancer, bone health, and menopause. While evidence-based guidelines for these aging-related conditions do not exist specifically for TGD adults, clinical practice and data from studies in TGD and cisgender adults are discussed to support the approaches to these patient cases. Future research in these areas can inform best practices and clinical guidelines for care of older TGD adults.
引用
- Rothman MS, van Heesewijk JO, Ariel D, et al. Approach to the patient: cases of hormonal management in older transgender and gender diverse adults. J Clin Endocrinol Metab. 2026. PMID: 42274359. doi:10.1210/clinem/dgag231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。